This study tested a new combination therapy in immuno oncology and found encouraging response rates with omaveloxolone plus ipilimumab or nivolumab in patients who were checkpoint inhibitor naïve or resistant. (sciencedaily.com)
Pedro de Noronha Pissarra, chief executive officer of Biotecnol said: «We're very proud to work with Cancer Research UK on the development of advanced clinical trial approaches in this competitive and highly promising field of immuno - oncology. (cancerresearchuk.org)
iTeos has developed an innovative phenotypic screening platform that is applied to the identification of rational combinations for our current programs, and to the discovery of novel targets for immuno - oncology. (iteostherapeutics.com)